Breaking Down the TRAILBLAZER-ALZ 2 Trial
Psychopharmacology and Psychiatry Updates
00:00
Innovative Treatment Approaches for Alzheimer's
This chapter explores the evaluation processes for candidates receiving lacanumab and denanimab for Alzheimer's disease. It highlights the distinct approach of denanimab, which allows for treatment cessation after amyloid plaque clearance, and emphasizes the importance of discussing these options with patients.
Transcript
Play full episode
